Skip to main content
Clinical Trials/CTRI/2022/03/040841
CTRI/2022/03/040841CompletedNot Applicable

Efficacy of Melatonin on post operative pain reduction in patients undergoing Head and Neck cancer surgery under General Anaesthesia- Prospective Randomized double blind controlled study.

All India Institute of Medical Sciences Rishikesh1 site in 1 country40 target enrollmentStarted: July 3, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
1
Primary Endpoint
To compare postoperative pain score (VAS score) up to 24 hours after surgery between melatonin and control group.

Study Overview

Brief Summary

Pain is defined as “An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage.†Over the past years, definition of pain has become multidimensional, as it is considered to be not just a sensation, but has also been described by several features such as quality perception, location, intensity, emotional impact and frequency. Melatonin  is  a  neurohormone  secreted  by  the  pineal  gland;  it  helps  to  maintain  circadian rhythm  of  sleep  cycle.  It  has  been  and  is  being  used  in  many  clinical  trials  with  diffe rent therapeutic  approaches.  It  has  sedative,  analgesic,  anti chronobiotic  effects.

Present study plans evaluate the efficacy of preoperative Melatonin on post operative pain reduction and preoperative anxiety reduction in patients undergoing Head and Neck cancer surgery under General Anaesthesia.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •ASA I and II.
  • •Patient of either sex.
  • •Age: 18 years-65 years.
  • •Patients posted for head and neck oncological surgery.

Exclusion Criteria

  • •Refusal of patient or relatives.
  • •Severe uncontrolled systemic diseases (DM/HTN/CAD/Valvular heart disease/Respiratory disease/Neuromuscular disorders/Epilepsy).
  • •Allergy to study drug.
  • •Patients with a history of chronic use of sedatives or analgesics especially opioids or gabapentanoids.

Outcomes

Primary Outcomes

To compare postoperative pain score (VAS score) up to 24 hours after surgery between melatonin and control group.

Time Frame: At the End of surgery, 30 minutes, 60 minutes, 90 minutes, 2 hours, 4 hours, 6 hours, 12 hours, 18 hours, 24 hours after end of surgery

Secondary Outcomes

  • Perioperative haemodynamic changes.(Perioperative period.)
  • Preoperative anxiety score.(Before start of surgery.)
  • Sedation score.(At the End of surgery, 30 minutes, 60 minutes, 90 minutes, 2 hours, 4 hours, 6 hours, 12 hours, 18 hours, 24 hours after end of surgery.)
  • Neutrophil Lymphocyte Ratio score.(Before and after surgery.)
  • Time to first analgesic requirement.(Postoperative period till 24 hours.)

Investigators

Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials